Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Congenital atrichia is a rare condition where children are born without hair, and treatment is often ineffective.

Araliadiol may promote hair growth like minoxidil without being toxic.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

AH-001 could be a safer and more effective treatment for hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.